# | Title | Journal | Year | Citations |
---|
1 | Topical Ocular Drug Delivery: Recent Developments and Future Challenges | Journal of Ocular Pharmacology and Therapeutics | 1986 | 416 |
2 | Trabeculectomy with Simultaneous Topical Application of Mitomycin-C in Refractory Glaucoma | Journal of Ocular Pharmacology and Therapeutics | 1990 | 403 |
3 | Glutathione: A Vital Lens Antioxidant | Journal of Ocular Pharmacology and Therapeutics | 2000 | 334 |
4 | Effects of Different Concentrations of Atropine on Controlling Myopia in Myopic Children | Journal of Ocular Pharmacology and Therapeutics | 1999 | 214 |
5 | Review: Oxidative Stress and Disease | Journal of Ocular Pharmacology and Therapeutics | 2000 | 205 |
6 | Causes Of Non-Compliance With Drug Regimens In Glaucoma Patients: A Qualitative Study | Journal of Ocular Pharmacology and Therapeutics | 2002 | 185 |
7 | Ocular Adverse Events Associated with Antibody–Drug Conjugates in Human Clinical Trials | Journal of Ocular Pharmacology and Therapeutics | 2015 | 183 |
8 | The Etiology of Steroid Cataract | Journal of Ocular Pharmacology and Therapeutics | 2007 | 175 |
9 | Curcumin Prevents Experimental Diabetic Retinopathy in Rats Through Its Hypoglycemic, Antioxidant, and Anti-Inflammatory Mechanisms | Journal of Ocular Pharmacology and Therapeutics | 2011 | 159 |
10 | Comparative Toxicity of Preservatives on Immortalized Corneal and Conjunctival Epithelial Cells | Journal of Ocular Pharmacology and Therapeutics | 2009 | 157 |
11 | Persistent Ocular Hypertension Following Intravitreal Bevacizumab and Ranibizumab Injections | Journal of Ocular Pharmacology and Therapeutics | 2010 | 148 |
12 | Ocular Hypotensive FP Prostaglandin (PG) Analogs: PG Receptor Subtype Binding Affinities and Selectivities, and Agonist Potencies at FP and Other PG Receptors in Cultured Cells | Journal of Ocular Pharmacology and Therapeutics | 2003 | 146 |
13 | Ginkgo biloba Extract Increases Ocular Blood Flow Velocity | Journal of Ocular Pharmacology and Therapeutics | 1999 | 140 |
14 | A Randomized, Placebo-Controlled Clinical Trial of Tacrolimus Ophthalmic Suspension 0.1% in Severe Allergic Conjunctivitis | Journal of Ocular Pharmacology and Therapeutics | 2010 | 138 |
15 | Novel Strategies for Anterior Segment Ocular Drug Delivery | Journal of Ocular Pharmacology and Therapeutics | 2013 | 138 |
16 | Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma | Journal of Ocular Pharmacology and Therapeutics | 2018 | 138 |
17 | Review: Practical Issues in Intravitreal Drug Delivery | Journal of Ocular Pharmacology and Therapeutics | 2001 | 136 |
18 | Recent Advances in Topical Ocular Drug Delivery | Journal of Ocular Pharmacology and Therapeutics | 2016 | 136 |
19 | Intraocular Pressure Homeostasis: Maintaining Balance in a High-Pressure Environment | Journal of Ocular Pharmacology and Therapeutics | 2014 | 130 |
20 | Contact Lenses: Promising Devices for Ocular Drug Delivery | Journal of Ocular Pharmacology and Therapeutics | 2013 | 125 |
21 | Intraocular Pressure Fluctuations in Medical versus Surgically Treated Glaucomatous Patients | Journal of Ocular Pharmacology and Therapeutics | 2002 | 121 |
22 | Pharmacotherapy of Glaucoma | Journal of Ocular Pharmacology and Therapeutics | 2015 | 121 |
23 | Preclinical Efficacy of Travoprost, a Potent and Selective FP Prostaglandin Receptor Agonist | Journal of Ocular Pharmacology and Therapeutics | 2001 | 113 |
24 | Adalimumab Therapy for Refractory Uveitis: A Pilot Study | Journal of Ocular Pharmacology and Therapeutics | 2008 | 113 |
25 | Resolvin E1 Improves Tear Production and Decreases Inflammation in a Dry Eye Mouse Model | Journal of Ocular Pharmacology and Therapeutics | 2010 | 111 |
26 | A Comparison Between the Fluocinolone Acetonide (Retisert) and Dexamethasone (Ozurdex) Intravitreal Implants in Uveitis | Journal of Ocular Pharmacology and Therapeutics | 2013 | 111 |
27 | Comparison of Toxicological Profiles of Benzalkonium Chloride and Polyquaternium-1: An Experimental Study | Journal of Ocular Pharmacology and Therapeutics | 2006 | 109 |
28 | Treatment of Ocular Toxocariasis with Albendazole | Journal of Ocular Pharmacology and Therapeutics | 2001 | 106 |
29 | In Situ-Forming Gels for Ophthalmic Drug Delivery | Journal of Ocular Pharmacology and Therapeutics | 1994 | 105 |
30 | Ocular Side-Effects Associated with Imatinib Mesylate (Gleevec®) | Journal of Ocular Pharmacology and Therapeutics | 2003 | 104 |
31 | Review: Effects of Nitric Oxide on Eye Diseases and Their Treatment | Journal of Ocular Pharmacology and Therapeutics | 2001 | 103 |
32 | The Role of TGF-β2 and Bone Morphogenetic Proteins in the Trabecular Meshwork and Glaucoma | Journal of Ocular Pharmacology and Therapeutics | 2014 | 103 |
33 | TheIn VitroandIn VivoOcular Pharmacology of Olopatadine (AL-4943A), an Effective Anti-Allergic/Antihistaminic Agent | Journal of Ocular Pharmacology and Therapeutics | 1996 | 102 |
34 | INS365 Suppresses Loss of Corneal Epithelial Integrity by Secretion of Mucin-like Glycoprotein in a Rabbit Short-term Dry Eye Model | Journal of Ocular Pharmacology and Therapeutics | 2002 | 102 |
35 | Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema: A Prospective, Randomized Study | Journal of Ocular Pharmacology and Therapeutics | 2006 | 101 |
36 | Review: Systemic Absorption of Topically Applied Ocular Drugs in Humans | Journal of Ocular Pharmacology and Therapeutics | 1990 | 100 |
37 | Ultraviolet Radiation and Cataract | Journal of Ocular Pharmacology and Therapeutics | 2000 | 99 |
38 | Effects of Prostaglandin Analogues on Aqueous Humor Outflow Pathways | Journal of Ocular Pharmacology and Therapeutics | 2014 | 99 |
39 | Topical Ophthalmic Beta Blockers: A Comparative Review | Journal of Ocular Pharmacology and Therapeutics | 1993 | 98 |
40 | Chitosan as Tear Substitute: A Wetting Agent Endowed with Antimicrobial Efficacy | Journal of Ocular Pharmacology and Therapeutics | 2000 | 98 |
41 | Review The Preclinical Pharmacology of Dorzolamide Hydrochloride, a Topical Carbonic Anhydrase Inhibitor | Journal of Ocular Pharmacology and Therapeutics | 1996 | 97 |
42 | Evaluation of Biomarkers of Inflammation in Response to Benzalkonium Chloride on Corneal and Conjunctival Epithelial Cells | Journal of Ocular Pharmacology and Therapeutics | 2009 | 96 |
43 | Dendrimer Nanoparticles for Ocular Drug Delivery | Journal of Ocular Pharmacology and Therapeutics | 2013 | 96 |
44 | Pharmacologic Control of Wound Healing in Glaucoma Filtration Surgery | Journal of Ocular Pharmacology and Therapeutics | 1989 | 95 |
45 | Ocular Pharmacokinetics of Fluocinolone Acetonide After Retisert™ Intravitreal Implantation in Rabbits Over a 1-Year Period | Journal of Ocular Pharmacology and Therapeutics | 2004 | 94 |
46 | Development of Effective Ocular Preparations of Antifungal Agents | Journal of Ocular Pharmacology and Therapeutics | 2008 | 93 |
47 | Reversibility of Ethambutol Optic Neuropathy | Journal of Ocular Pharmacology and Therapeutics | 1997 | 92 |
48 | Effect of Needle Type and Injection Technique on Pain Level and Vitreal Reflux in Intravitreal Injection | Journal of Ocular Pharmacology and Therapeutics | 2011 | 91 |
49 | Cytomegalovirus Retinitis: A Review | Journal of Ocular Pharmacology and Therapeutics | 2017 | 91 |
50 | Agonist Activity of Bimatoprost, Travoprost, Latanoprost, Unoprostone Isopropyl Ester and Other Prostaglandin Analogs at the Cloned Human Ciliary Body FP Prostaglandin Receptor | Journal of Ocular Pharmacology and Therapeutics | 2002 | 88 |